Thermoresponsive arginine-based hydrogels as biologic carriers
Cationic poly(ester amide) (PEA)-based hydrogels are provided. The hydrogels are fabricated from unsaturated L-arginine base poly(ester-amide) (UArg-PEA) precursors, pluronicDA precursors, or a combination of UArg-PEA and pluronicDA precursors at predetermined precursor composition ratios. PluronicDA/UArg-PEA hybrid hydrogels and pure pluronicDA based hydrogels are thermoresponsive and biodegradable, while pure UArg-PEA base hydrogels are biodegradable but not thermoresponsive. UArg-PEA based, pluronicDA based and hybrid hydrogels can be synthesized from unsaturated arginine-based PEA salts and/or unsaturated pluronic acid polymers. Unsaturated pluronic acid polymers can be synthesized by reacting pluronic acid with acryloylchloride to provided functional vinyl groups at the two chain ends of pluronic acid. The hydrogels can be used to carry and/or release molecules or compounds such as bioactive compounds, and can function as biologic carriers for a variety of biomedical applications.
1. A hybrid hydrogel comprising a plurality of crosslinked polymers wherein the polymers prior to polymerization and crosslinking have a chemical formula described by:
the general structural Formula (I),
Formula (I)
wherein y=1-20 and n=5-600, and
the general structural Formula (II),
wherein m=10-90 and n=1-150.
2. The hybrid hydrogel of claim 1 having thermoresponsive properties.
3. A method for controlling release of a molecule or compound comprising: providing the hydrogel of claim 1 , wherein the molecule or compound is loaded in the hydrogel.
4. A method for directing release of a molecule or compound in an area of interest comprising:
providing the hydrogel of claim 1 , wherein the molecule or compound is loaded in the hydrogel and wherein the hydrogel is inserted in the area of interest.
5. The method of claim 3 wherein the molecule or compound is a bioactive molecule or compound.
6. The method of claim 5 wherein the molecule or compound is a nutrient, pharmaceutical, drug, peptide, polypeptide, oligonucleotide or polynucleotide.
7. An apparatus for controlling release of a molecule or compound comprising the hydrogel of claim 1 .
8. An apparatus for directing release of a molecule or compound in an area of interest comprising the hydrogel of claim 1 .
9. The apparatus of claim 7 wherein the molecule or compound is a bioactive molecule or compound.
10. The apparatus of claim 9 wherein the molecule or compound is a nutrient, pharmaceutical, drug, peptide, polypeptide, oligonucleotide or polynucleotide.
11. The method of claim 4 wherein the molecule or compound is a bioactive molecule or compound.
12. The method of claim 11 wherein the molecule or compound is a nutrient, pharmaceutical, drug, peptide, polypeptide, oligonucleotide or polynucleotide.
13. The apparatus of claim 8 wherein the molecule or compound is a bioactive molecule or compound.
14. The apparatus of claim 13 wherein the molecule or compound is a nutrient, pharmaceutical, drug, peptide, polypeptide, oligonucleotide or polynucleotide.